Verratti Mark 4

What Happened Mark Verratti, Chief Operating Officer of Myriad Genetics (MYGN), had 2,055 shares of common stock withheld by the company to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units (RSUs). The withholding was recorded on 2026-03-22 at an effective price of $4.58 per share, totaling $9,412. This was a tax-withholding disposition (not an open-market sale or purchase) and is generally a routine administrative action.

Key Details

• Transaction date: 2026-03-22; reported on Form 4 filed 2026-03-23 (appears timely).
• Price used: $4.58 per share; total value of shares withheld: $9,412.
• Shares withheld: 2,055 shares (reported as a disposition under code F — tax withholding).
• Shares owned after the transaction: not specified in the provided filing summary.
• Footnote: The number of shares withheld was determined based on Myriad's closing stock price on March 20, 2026.

Context This transaction represents company-withheld shares to cover tax liabilities from RSU vesting (footnote F1), not an indicator of a deliberate sale or purchase by the insider. Such withholdings are common when equity grants vest and do not necessarily reflect the insider’s view of the stock.